{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:39:56Z","timestamp":1780396796313,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00347-016-0262-4","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T08:24:44Z","timestamp":1462263884000},"page":"391-397","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Juvenile idiopathische Arthritis-assoziierte Uveitis","Uveitis associated with juvenile idiopathic arthritis"],"prefix":"10.1007","volume":"113","author":[{"given":"A.","family":"Heiligenhaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tappeiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Walscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,3]]},"reference":[{"key":"262_CR1","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00417-013-2436-y","volume":"251","author":"A Adan","year":"2013","unstructured":"Adan A, Mesquida M, Llorenc V et al (2013) Tocilizumab treatment for refractory uveitis-related cystoid macular edema. Graefes Arch Clin Exp Ophthalmol 251:2627\u20132632","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"262_CR2","first-page":"1897","volume":"35","author":"S Angeles-Han","year":"2008","unstructured":"Angeles-Han S, Flynn T, Lehman T (2008) Abatacept for refractory juvenile idiopathic arthritis-associated uveitis- a case report. J Rheumatol 35:1897\u20131898","journal-title":"J Rheumatol"},{"key":"262_CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bjo.2006.103721","volume":"91","author":"S Biester","year":"2007","unstructured":"Biester S, Deuter C, Michels H et\u00a0al (2007) Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol 91:319\u2013324","journal-title":"Br J Ophthalmol"},{"key":"262_CR4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00296-015-3231-3","volume":"35","author":"R Bou","year":"2015","unstructured":"Bou R, Adan A, Borras F et\u00a0al (2015) Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panal consensus. Rheumatol Int 35:777\u2013785","journal-title":"Rheumatol Int"},{"key":"262_CR5","author":"C Garcia-De-Vicuna","year":"2013","unstructured":"Garcia-De-Vicuna C, Diaz-Llopis M, Salom D et al (2013) Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis. Mediators Inflamm. doi:10.1155\/2013\/560632","journal-title":"Mediators Inflamm"},{"key":"262_CR6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/bjo.2009.173542","volume":"95","author":"JC Goebel","year":"2011","unstructured":"Goebel JC, Roesel M, Heinz C et\u00a0al (2011) Azathiorpin as a treatment option for uveitis in patients with juvenile idiopathic arthritis. Br J Ophthalmol 95:209\u2013213","journal-title":"Br J Ophthalmol"},{"key":"262_CR7","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","volume":"46","author":"A Heiligenhaus","year":"2007","unstructured":"Heiligenhaus A, Niewerth M, Ganser G et al (2007) Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology 46:1015\u20131019","journal-title":"Rheumatology"},{"key":"262_CR8","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/rheumatology\/ker107","volume":"50","author":"A Heiligenhaus","year":"2011","unstructured":"Heiligenhaus A, Miserocchi E, Heinz C et al (2011) Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab). Rheumatology 50:1390\u20131394","journal-title":"Rheumatology"},{"key":"262_CR9","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00296-011-2126-1","volume":"32","author":"A Heiligenhaus","year":"2012","unstructured":"Heiligenhaus A, Michels H, Schumacher C et al (2012) Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int 32:1121\u20131133","journal-title":"Rheumatol Int"},{"key":"262_CR10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3109\/09273948.2013.791701","volume":"21","author":"A Heiligenhaus","year":"2013","unstructured":"Heiligenhaus A, Heinz C, Edelsten C et\u00a0al (2013) Review of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm 21:180\u2013191","journal-title":"Ocul Immunol Inflamm"},{"key":"262_CR11","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/bjophthalmol-2011-301023","volume":"96","author":"M Hoeve","year":"2012","unstructured":"Hoeve M, Kalinina AV, Schalij-Delfos NE et al (2012) The clinical course of juvenile idiopathic arthritis-associated uveitis in childhood and puberty. Br J Ophthalmol 96:852\u2013856","journal-title":"Br J Ophthalmol"},{"key":"262_CR12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajo.2010.08.021","volume":"151","author":"AV Kalinina","year":"2011","unstructured":"Kalinina AV, Winkel EL van de, Rothova A et al (2011) Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis. Am J Ophthalmol 151:217\u2013222","journal-title":"Am J Ophthalmol"},{"key":"262_CR13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2015.04.016","volume":"160","author":"Lerman","year":"2015","unstructured":"Lerman et\u00a0al (2015) Uveitis reactivation in children treated with tumor necrosis factor alpha inhibitors. Am J Ophthalmol 160:193\u2013200","journal-title":"Am J Ophthalmol"},{"key":"262_CR14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ophtha.2010.07.031","volume":"118","author":"E Miserocchi","year":"2011","unstructured":"Miserocchi E, Pontikaki I, Modorati G et\u00a0al (2011) Rituximab for uveitis. Ophthalmology 118:223\u2013224","journal-title":"Ophthalmology"},{"key":"262_CR15","first-page":"320","volume":"31","author":"E Miserocchi","year":"2013","unstructured":"Miserocchi E, Modorati G, Pontikaki I et\u00a0al (2013) Golimumab treatment for complicated uveitis. Clin Exp Rheumatol 31:320\u2013321","journal-title":"Clin Exp Rheumatol"},{"key":"262_CR16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/09273948.2013.844265","volume":"22","author":"E Miserocchi","year":"2014","unstructured":"Miserocchi E, Modorati G, Pontikaki I et al (2014) Long-term treatment with golimumab for severe uveitis. Ocul Immunol Inflamm 22:90\u201395","journal-title":"Ocul Immunol Inflamm"},{"key":"262_CR17","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.ophtha.2008.03.027","volume":"115","author":"JG Parikh","year":"2008","unstructured":"Parikh JG, Tawansy KA, Rao NA (2008) Immunohistochemical study of chronic nongranulomatous anterior uveitis in juvenile idiopathic arthritis. Ophthalmology 115:1833\u20131836","journal-title":"Ophthalmology"},{"key":"262_CR18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","volume":"48","author":"P Quartier","year":"2003","unstructured":"Quartier P, Taupin P, Bourdeaut F et\u00a0al (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48:1093\u20131101","journal-title":"Arthritis Rheum"},{"key":"262_CR19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/acr.20404","volume":"63","author":"G Simonini","year":"2011","unstructured":"Simonini G, Taddio A, Cattalini M et al (2011) Prevention of flare recurrences in childhood-refractory chronic uveiis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res 63:612\u2013618","journal-title":"Arthritis Care Res"},{"key":"262_CR20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/acr.22214","volume":"66","author":"G Simonini","year":"2014","unstructured":"Simonini G, Druce K, Cimaz R et al (2014) Current evidence of anti-tumor necrosis factor a treatment efficacy in childhood chronic uveitis: a systemic review and meta-analysis approach of individual drugs. Arthritis Care Res (Hoboken) 66:1073\u20131084","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"262_CR21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/art.20904","volume":"53","author":"JA Smith","year":"2005","unstructured":"Smith JA, Thompson DJ, Whitcup SM et al (2005) A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 53:18\u201323","journal-title":"Arthritis Rheum"},{"key":"262_CR22","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3899\/jrheum.120010","volume":"39","author":"C Tappeiner","year":"2012","unstructured":"Tappeiner C, Heinz C, Ganser G et\u00a0al (2012) Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis. J\u00a0Rheumatol 39:1294\u20131295","journal-title":"J Rheumatol"},{"key":"262_CR23","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3899\/jrheum.140410","volume":"42","author":"C Tappeiner","year":"2015","unstructured":"Tappeiner C, Miserocchi E, Bodaghi B et\u00a0al (2015) Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis. J\u00a0Rheumatol 42:706\u2013711","journal-title":"J Rheumatol"},{"key":"262_CR24","first-page":"\u25a0","volume":"\u25a0","author":"C Tappeiner","year":"2015","unstructured":"Tappeiner C, Klotsche J, Schenck S et al (2015) Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis: data from a cross-sectional analysis of a prospective nation-wide study. Clin Exp Rheumatol : (in print)","journal-title":"Clin Exp Rheumatol"},{"key":"262_CR25","author":"C Tappeiner","year":"2015","unstructured":"Tappeiner C, Schenk S, Niewerth M et al (2015) Impact of anti-inflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: longitudinal analysis from a nation-wide paediatric rheumatological database. Arthritis Care Res. doi:10.1002\/acr.22649","journal-title":"Arthritis Care Res"},{"key":"262_CR26","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ajo.2007.01.033","volume":"143","author":"JE Thorne","year":"2007","unstructured":"Thorne JE, Woreta FA, Kedhar SR et al (2007) Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol 143:840\u2013846","journal-title":"Am J Ophthalmol"},{"key":"262_CR27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/ard.2006.058248","volume":"66","author":"O Tynj\u00e4l\u00e4","year":"2007","unstructured":"Tynj\u00e4l\u00e4 O, Lindahl P, Honkanen V et\u00a0al (2007) Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis 66:548\u2013550","journal-title":"Ann Rheum Dis"},{"key":"262_CR28","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jpeds.2006.04.058","volume":"149","author":"LB Vasquez-Cobian","year":"2006","unstructured":"Vasquez-Cobian LB, Flynn T, Lehman TJ (2006) Adalimumab therapy for childhood uveitis. J Pediatr 149:572\u2013575","journal-title":"J Pediatr"},{"key":"262_CR29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3899\/jrheum.120583","volume":"40","author":"ME Zannin","year":"2013","unstructured":"Zannin ME, Birolo C, Gerloni VM et al (2013) Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1\u2011year followup data from the Italian registry. J Rheumatol 40:74\u201379","journal-title":"J Rheumatol"},{"key":"262_CR30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/acr.20115","volume":"62","author":"F Zulian","year":"2010","unstructured":"Zulian F, Balzarin M, Falconi F et al (2010) Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis. Arthritis Care Res (Hoboken) 62:821\u2013825","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-016-0262-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-016-0262-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-016-0262-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:52:05Z","timestamp":1559051525000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-016-0262-4"}},"subtitle":["Optimierung der immunmodulierenden Therapie","Optimization of immunomodulatory therapy"],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1007\/s00347-016-0262-4","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}